Skip to main content

Streamline Your Mycoplasma Testing With BIOFIRE® Mycoplasma

In the high-stakes world of cell and gene therapy, timely and accurate mycoplasma testing is crucial. BIOFIRE® Mycoplasma delivers a transformative solution with its 1-hour in-house testing, designed to maximize efficiency and cut costs without compromising quality.

BIOFIRE® Mycoplasma Offers Cell & Gene Therapy Manufacturers the “Molecular Lab in a Pouch”:

BIOFIRE® Mycoplasma uses next-gen PCR technology to deliver in-house testing results in under an hour, saving you time and money on outsourced testing without adding significant workload. 

Its simple three-step workflow process requires no expertise, with just two minutes of hands-on time and no result interpretation. The closed “molecular lab in a pouch” ensures data integrity, making rapid, reliable mycoplasma results possible.

   

Why BIOFIRE® Mycoplasma for Cell & Gene Therapies?

  • Fast Results
    Get reliable mycoplasma results in under one hour with BIOFIRE® Mycoplasma’s next-gen PCR technology, reducing dependence on costly outsourced testing.
  • Simple Workflow
    Perform accurate testing easily with a three-step process that requires only two minutes of hands-on time and no result interpretation.
  • Secure and Efficient
    Enjoy a “molecular lab in a pouch” with a closed-system design that ensures data integrity and integrates seamlessly into your lab.
  • Cost Savings
    Cut costs and improve efficiency by bringing mycoplasma testing in-house, eliminating expenses for outsourced services and optimizing lab resources.

Interested in Saving Time and Money While Improving Your Testing Accuracy?

Contact our experts today for more information on BIOFIRE® Mycoplasma.

Discover how BIOFIRE® Mycoplasma “Molecular Lab in a Pouch” Automates Testing with a Shorter Time-To-Result

On-Demand Webinar

Regulatory Submission Strategy for Implementation and Validation of a New PCR-Based Technology for Mycoplasma Testing

Experts from Janssen, Pharmaceutical Companies of Johnson & Johnson, discuss their validation approach and strategy for PCR-based mycoplasma testing.

ACCESS WEBINAR

WHITE PAPER

Real-World Data From Cell Therapy Manufacturers 

Two cell therapy manufacturers evaluated the BIOFIRE® FILMARRAY® 2.0 system for mycoplasma detection. Interested in the results? 

DOWNLOAD WHITE PAPER

PRODUCT PAGE

BIOFIRE® MYCOPLASMA

Did you know mycoplasma testing could be so easy? Discover the value of simplicity and take control of your process.

MORE DETAILS

Scientific Study Summary

BIOFIRE® Mycoplasma For Cell & Gene Therapy Samples

Two cell therapy and four bioproduction manufacturers evaluted the BIOFIRE® FILMARRAY® 2.0 — interested in the results in an easy-to-digest format? Download a one page Scientific Study Summary that details the study's objectives, outline, and conclusion!
DOWNLOAD
ATMP Cells Image

Cell & Gene Therapy Solutions

There’s no time to lose when a patient relies on your product. Streamlined quality control testing specific to cell and gene therapies yields safe, rapid and efficient results.

Discover Our Proven Portfolio Of Value-Added Solutions